Your Beauty Review Limited 30/04/2025 iXBRL

Company registration number: 12573505

Your Beauty Review Limited

Unaudited filleted financial statements

30 April 2025

Your Beauty Review Limited

Contents

Directors and other information

Accountants report

Statement of financial position

Notes to the financial statements

Your Beauty Review Limited

Directors and other information


	Directors	Richard John Merrick
		Jo-Ann Merrick


	Company number	12573505


	Registered office	129 Trewyddfa Road
		Morriston
		Swansea
		SA6 8NY


	Accountants	Morgan Hemp & Co
		103-104
		Walter Road
		Swansea
		SA1 5QF

Your Beauty Review Limited

Report to the board of directors on the preparation of the

unaudited statutory financial statements of Your Beauty Review Limited

Year ended 30 April 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Your Beauty Review Limited for the year ended 30 April 2025 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants , we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/ professional-standards/ rules-standards/acca-rulebook.html.

This report is made solely to the board of directors of Your Beauty Review Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Your Beauty Review Limited and state those matters that we have agreed to state to the board of directors of Your Beauty Review Limited as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/content/dam/ACCA_Global /Technical/fact/technical-factsheet-163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Your Beauty Review Limited and its board of directors as a body for our work or for this report.

It is your duty to ensure that Your Beauty Review Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Your Beauty Review Limited. You consider that Your Beauty Review Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Your Beauty Review Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Morgan Hemp & Co

Chartered Certified Accountants

103-104

Walter Road

Swansea

SA1 5QF

7 January 2026

Your Beauty Review Limited

Statement of financial position

30 April 2025

		2025		2024
	Note	£	£	£	£

Fixed assets
Intangible assets	4	2,337		2,805
Tangible assets	5	869		1,310
		_______		_______
			3,206		4,115

Current assets
Debtors	6	5,111		4,937
Cash at bank and in hand		196		610
		_______		_______
		5,307		5,547
Creditors: amounts falling due
within one year	7	( 27,749)		( 30,029)
		_______		_______
Net current liabilities			( 22,442)		( 24,482)
			_______		_______
Total assets less current liabilities			( 19,236)		( 20,367)

			_______		_______
Net liabilities			( 19,236)		( 20,367)
			_______		_______

Capital and reserves
Called up share capital			100		100
Profit and loss account			( 19,336)		( 20,467)
			_______		_______
Shareholders deficit			( 19,236)		( 20,367)
			_______		_______

For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 07 January 2026 , and are signed on behalf of the board by:

Richard John Merrick

Director

Company registration number: 12573505

Your Beauty Review Limited

Notes to the financial statements

Year ended 30 April 2025

1. General information

The company is a private company limited by shares, registered in Wales. The address of the registered office is 129 Trewyddfa Road, Morriston, Swansea, SA6 8NY.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Intangible assets

Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at a revalued amount, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Research and development

Research expenditure is written off in the year in which it is incurred. Development expenditure incurred is capitalised as an intangible asset only when all of the following criteria are met: - It is technically feasible to complete the intangible asset so that it will be available for use or sale; - There is the intention to complete the intangible asset and use or sell it; - There is the ability to use or sell the intangible asset; - The use or sale of the intangible asset will generate probable future economic benefits; - There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and - The expenditure attributable to the intangible asset during its development can be measured reliably. Expenditure that does not meet the above criteria is expensed as incurred.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

4. Intangible assets

	Other intangible assets	Total
	£	£
Cost
At 1 May 2024 and 30 April 2025	4,674	4,674
	_______	_______
Amortisation
At 1 May 2024	1,870	1,870
Charge for the year	467	467
	_______	_______
At 30 April 2025	2,337	2,337
	_______	_______
Carrying amount
At 30 April 2025	2,337	2,337
	_______	_______
At 30 April 2024	2,804	2,804
	_______	_______

5. Tangible assets

	Fixtures, fittings and equipment	Total
	£	£
Cost
At 1 May 2024	4,534	4,534
Additions	582	582
	_______	_______
At 30 April 2025	5,116	5,116
	_______	_______
Depreciation
At 1 May 2024	3,224	3,224
Charge for the year	1,023	1,023
	_______	_______
At 30 April 2025	4,247	4,247
	_______	_______
Carrying amount
At 30 April 2025	869	869
	_______	_______
At 30 April 2024	1,310	1,310
	_______	_______

6. Debtors

	2025	2024
	£	£
Trade debtors	1,800	1,260
Other debtors	3,311	3,677
	_______	_______
	5,111	4,937
	_______	_______

7. Creditors: amounts falling due within one year

	2025	2024
	£	£
Other creditors	27,749	30,029
	_______	_______

8. Related party transactions

Included within creditors are amounts owed to the directors totalling £27,274 (2024: £29,254). The loan is interest free and repayable on demand.